Le Lézard
Classified in: Health
Subjects: TDS, WOM, FVT

binx health To Present At The Canaccord Genuity Medical Technology And Diagnostics Forum


BOSTON, Nov. 19, 2019 /PRNewswire/ -- binx health, the pioneer in anywhere, anytime testing for women's health, today announced that Jeffrey Luber, president and CEO is scheduled to present on Thursday, November 21, 2019 at 11:00 a.m. ET at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York City.

binx health is the pioneer in anywhere care for consumers where they live, work and shop. binx develops proprietary, rapid desktop PCR instruments and mobile solutions for at home, physician-ordered testing to bring consumers from "worry-to-well" quickly and effectively. For more visit www.mybinxhealth.com (PRNewsfoto/binx health)

Management will be available for one-on-one meetings throughout the conference. The presentation will be webcast live and may be accessed by visiting https://mybinxhealth.com/category/news/ on the News section of the company's website.

ABOUT BINX HEALTH
binx health is the pioneer in anywhere care in women's health for consumers where they live, work and shop. With the first FDA 510(k) cleared solution for the rapid testing of Chlamydia (CT) and Gonorrhea (NG) in women, binx is poised to transform care for the two most tested for sexually-transmitted infections globally. Today, 40% of patients who test positive for CT/NG do not come back for treatment once they leave a physician's office?making the need for rapid test and treat solutions paramount. We also expand access to testing through mobile solutions for at-home, physician-ordered testing that aim to bring consumers from "worry-to-well" in the palm of their hands, for those unwilling or unable to get tested in-clinic. Starting with sexually-transmitted infections, we aim to reverse trends of rising infections among young people wherever they are, and move into broader family health through the expansion of our point-of-care and at-home menus. binx health's investors include financial investors Johnson & Johnson Innovation, Novartis Venture Fund, LSP, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors Consort Medical (whose wholly owned subsidiary Bespak is the manufacturer of the company's low-cost, proprietary multiplex cartridges) and China-based Wondfo Biotech.

SOURCE binx health


These press releases may also interest you

at 15:45
Local residents have a new reason to smile. Baystate Dental has recently opened a new, state-of-the-art dental practice, located at 98 Lower Westfield Road, Suite 204, Holyoke, MA. Baystate Dental of Holyoke is fully equipped to provide...

at 15:35
In search of treatments for human diseases, medical researchers rely on the latest technologies to gather vast amounts of information. Genomics studies, for example, collect data about millions of DNA sequences, generating huge datasets. To decipher...

at 15:30
Haemonetics Corporation , a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today opened its new global headquarters in Boston. The new space supports Haemonetics' work to...

at 15:30
Medico of South Carolina "(Medico") is a medical billing company for covered entities. On September 16, 2019, Medico mailed letters to some individuals potentially affected by a security incident.    On June 20, 2019, a security research firm...

at 15:30
The "Fractional Flow Reserve Market Size, Share & Trends Analysis Report By Application (Multi-Vessel CAD, Single-Vessel CAD), By Product (Monitoring Systems, Guidewires), By Region, and Segment Forecasts, 2019 - 2026" report has been added to...

at 15:18
Today, the co-chairs of the federal, provincial, and territorial Special Advisory Committee on the Epidemic of Opioid Overdoses?Dr. Theresa Tam, Chief Public Health Officer of Canada, and Dr. Saqib Shahab, Saskatchewan's Chief Medical Health...



News published on 19 november 2019 at 08:30 and distributed by: